Stockscreener 앱 받기
2.23
0.45%
-0.01
Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스
Momentum Shift: Is TherapeuticsMD Inc stock a falling knife or bargain buyGap Down & Weekly High Return Stock Opportunities - baoquankhu1.vn
Is TherapeuticsMD Inc forming a double bottomEarnings Trend Report & Reliable Trade Execution Plans - baoquankhu1.vn
Sell Signal: What is the fair value of TherapeuticsMD Inc stock nowMarket Performance Report & Verified Momentum Stock Watchlist - Bộ Nội Vụ
Gains Recap: Why retail investors pile into TherapeuticsMD Inc stockRate Hike & Daily Volume Surge Signals - Bộ Nội Vụ
Portfolio Shifts: Is TherapeuticsMD Inc stock heavily shortedMarket Sentiment Report & Growth Focused Stock Pick Reports - baoquankhu1.vn
Institution Moves: How strong is TherapeuticsMD Inc stock revenue growthJuly 2025 Outlook & Reliable Entry Point Alerts - Bộ Nội Vụ
TherapeuticsMD Reports Q3 2025 Financial Results - MSN
Why TherapeuticsMD Inc. stock could be next big winnerShare Buyback & Accurate Buy Signal Alerts - Улправда
Is TherapeuticsMD Inc. stock a buy for dividend growthCPI Data & Weekly Setup with ROI Potential - Улправда
Will TherapeuticsMD Inc. stock continue upward momentum2025 Trade Ideas & Stepwise Trade Execution Plans - Улправда
Is TherapeuticsMD Inc. stock a safe haven asset2025 Performance Recap & Free Community Consensus Stock Picks - Улправда
Can TherapeuticsMD Inc. stock rebound after recent weaknessChart Signals & Smart Investment Allocation Tips - Улправда
Can TherapeuticsMD Inc. stock deliver strong Q4 earningsJuly 2025 EndofMonth & Community Trade Idea Sharing - Улправда
Chart Watch: Can TherapeuticsMD Inc. stock deliver strong Q4 earningsQuarterly Profit Report & Weekly Top Gainers Trade List - Улправда
How strong is TherapeuticsMD Inc. stock revenue growthTreasury Yields & Technical Pattern Recognition Alerts - Улправда
Analysis Recap: Why TherapeuticsMD Inc. stock could be next big winner2025 Key Lessons & Detailed Earnings Play Strategies - Улправда
Will TherapeuticsMD Inc. stock deliver long term returnsFibonacci Extensions & Easy Tools to Analyze Your Investment Risk - Улправда
EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire
Fund Flows: Why TherapeuticsMD Inc stock could be next big winnerMarket Sentiment Review & Stepwise Entry/Exit Trade Alerts - Bộ Nội Vụ
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Slips 3.4%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD approves key proposals at annual meeting - MSN
TherapeuticsMD Inc. Stock Rallies 3.7%, Outperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why hedge funds are buying TherapeuticsMD Inc. stockWeekly Trade Report & Intraday High Probability Setup Alerts - Улправда
Rate Cut: Will TherapeuticsMD Inc. stock deliver long term returnsEarnings Overview Report & AI Powered Market Entry Strategies - Улправда
MSN Money - MSN
TherapeuticsMD Earnings Notes - Trefis
Block Trades: How currency fluctuations impact TherapeuticsMD Inc. stock2025 Momentum Check & Advanced Technical Analysis Signals - ulpravda.ru
How supply chain issues affect TherapeuticsMD Inc. stockJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда
Dilution adjustment of TherapeuticsMD, Inc. – FWB:29TA - TradingView — Track All Markets
TherapeuticsMD Approves Key Proposals at Annual Meeting - TipRanks
TherapeuticsMD (NASDAQ: TXMD) investors approve 2025 votes, 640M share authorization - Stock Titan
Price to earnings ratio of TherapeuticsMD, Inc. – DUS:29TA - TradingView — Track All Markets
29TA Stock Price and Chart — DUS:29TA - TradingView — Track All Markets
TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Dip Buying: Is TherapeuticsMD Inc stock attractive for income investorsIPO Watch & AI Based Trade Execution Alerts - moha.gov.vn
With TherapeuticsMD Stock Surging, Have You Considered The Downside? - Trefis
TherapeuticsMD (TXMD) Stock Analysis Report | Financials & Insights - Benzinga
TherapeuticsMD, Inc. (TXMD) -6.3% in After-hours: Price Decline Despite Recent Results - Stocks Telegraph
Will TherapeuticsMD Inc. (29TA) stock profit from automation waveEarnings Miss & Weekly Watchlist of Top Performers - Newser
Will TherapeuticsMD Inc. (29TA) stock sustain bullish trend into 2025Trade Risk Summary & Safe Entry Zone Identification - Newser
Can TherapeuticsMD Inc. (29TA) stock test all time highsJuly 2025 Setups & Step-by-Step Trade Execution Guides - Newser
Is TherapeuticsMD Inc. stock affected by interest rate hikes - Newser
TherapeuticsMD Inc. Stock Sheds 3.9%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
TherapeuticsMD Announces Pricing of Offering of Common Stock - AOL.com
1.30%
1.45%
자본화:
|
볼륨(24시간):